Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Front Public Health ; 9: 779192, 2021.
Article in English | MEDLINE | ID: mdl-35096739

ABSTRACT

Background: Little epidemiological research has investigated the associations of air pollutant exposure over various time windows with older adults' symptoms of depression. This study aimed to analyze the relationships of long- and short-term ambient air pollution exposure (to coarse particulate matter, O3, SO2, CO, and NOx) with depressive symptoms in a sample of community-dwelling older adults. Methods: A sample of older adults (n = 1,956) was recruited from a nationally representative multiple-wave study (Taiwan Longitudinal Study on Aging). Between 1996 and 2007, four waves of surveys investigated depressive symptoms by using the 10-item Center for Epidemiologic Studies Depression questionnaire. We approximated air pollutant concentrations from 1995 to 2007 by using daily concentration data for five air pollutants at air quality monitoring stations in the administrative zone of participants' residences. after adjusting for covariates, we applied generalized linear mixed models to analyze associations for different exposure windows (7-, 14-, 21-, 30-, 60-, 90-, and 180-day and 1-year moving averages). Results: In a one-pollutant model, long- and short-term exposure to CO and NOx was associated with heightened risks of depressive symptoms; the odds ratio and corresponding 95% confidence interval for each interquartile range (IQR) increment in CO at 7-, 14-, 21-, 30-, 60-, 90-, and 180-day and 1-year moving averages were 1.232 (1.116, 1.361), 1.237 (1.136, 1.348), 1.216 (1.128, 1.311), 1.231 (1.133, 1.338), 1.224 (1.124, 1.332), 1.192 (1.106, 1.285), 1.228 (1.122, 1.344), and 1.180 (1.102, 1.265), respectively. Those for each IQR increment in NOx were 1.312 (1.158, 1.488), 1.274 (1.162, 1.398), 1.295 (1.178, 1.432), 1.310 (1.186, 1.447), 1.345 (1.209, 1.496), 1.348 (1.210, 1.501), 1.324 (1.192, 1.471), and 1.219 (1.130, 1.314), respectively. The exposure to PM10, O3, and SO2 over various windows were not significant. In the two-pollutant model, only the associations of NOx exposure with depressive symptoms remained robust after adjustment for any other pollutant. Conclusions: Exposure to traffic-associated air pollutants could increase depression risks among older adults.


Subject(s)
Air Pollutants , Aged , Aging , Air Pollutants/adverse effects , Air Pollutants/analysis , Depression/epidemiology , Humans , Longitudinal Studies , Taiwan/epidemiology
2.
J Chin Med Assoc ; 80(8): 526-527, 2017 08.
Article in English | MEDLINE | ID: mdl-28601628
6.
J Chin Med Assoc ; 80(4): 269-270, 2017 04.
Article in English | MEDLINE | ID: mdl-28169207
8.
Int J Mol Sci ; 17(7)2016 Jul 07.
Article in English | MEDLINE | ID: mdl-27399682

ABSTRACT

This study was conducted to determine the risk of chronic kidney disease (CKD) among women with endometriosis in Taiwan. We conducted a retrospective cohort study using the National Health Insurance Research Database of Taiwan. A total of 27,973 women with a diagnosis of endometriosis and 27,973 multivariable-matched controls (1:1) from 2000 to 2010 were selected. Cox regression and computed hazard ratios (HR) with 95% confidence intervals (95% CI) were used to determine the risk of CKD among women with endometriosis. The incidence rates (IR, per 10,000 person-years) of CKD among women with and without endometriosis were 4.64 and 7.01, respectively, with a significantly decreased risk of CKD (crude HR 0.65, 95% CI 0.53-0.81; adjusted HR 0.69, 95% CI 0.56-0.86) among women with endometriosis. The IR of CKD progressively increased with age, but the trend of lower CKD risk among women with endometriosis was consistent. However, the lower risk of CKD in women with endometriosis was no longer statistically significant after adjusting for menopausal status (adjusted HR 0.85, 95% CI 0.65-1.10). The results suggest that endometriosis is inversely associated with CKD, but this effect was mediated by menopause. The possible mechanism of this association is worthy of further evaluation.


Subject(s)
Endometriosis/diagnosis , Renal Insufficiency, Chronic/diagnosis , Adult , Aged , Case-Control Studies , Cohort Studies , Databases, Factual , Endometriosis/complications , Female , Humans , Menopause , Middle Aged , Prevalence , Proportional Hazards Models , Renal Insufficiency, Chronic/epidemiology , Renal Insufficiency, Chronic/etiology , Retrospective Studies , Risk Factors , Taiwan/epidemiology
9.
Medicine (Baltimore) ; 94(39): e1633, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26426652

ABSTRACT

This article aims to test the hypothesis that the risk of epithelial ovarian cancer (EOC) in women with endometriosis might be changed by enrolling different population. A nationwide 14-year historic cohort study using the National Health Insurance Research Database (NHIRD) of Taiwan and the Registry for Catastrophic Illness Patients was conducted. A total of 239,385 women aged between 20 and 51 years, with at least 1 gynecologic visit after 2000, were analyzed. Cases included women with a diagnosed endometriosis, which was established along a spectrum from at least 1 medical record of endometriosis (recalled endometriosis) to tissue-proved ovarian endometriosis (n = X). Controls included women without any diagnosis of endometriosis (n = 239,385 - X). We used Cox regression, and computed hazard ratios (HRs) with 95% confidence intervals (95% CI) to determine the risk of EOC in patients. The EOC incidence rates (IRs, per 10,000 person-years) of women with endometriosis ranged from 1.90 in women with recalled endometriosis to 18.70 in women with tissue-proved ovarian endometrioma, compared with those women without any diagnosis of endometriosis (0.77-0.89), contributing to crude HRs ranging from 2.59 (95% CI, 2.09-3.21; P < 0.001) to 24.04 (95% CI, 17.48-33.05; P < 0.001). After adjustment for pelvic inflammatory disease, infertility, Charlson co-morbidity index, and age, adjusted HRs were ranged from the lowest of 1.90 (95% CI, 1.51-2.37; P < 0.001) in recalled endometriosis to the highest of 18.57 (95% CI, 13.37-25.79; P < 0.001) in tissue-proved ovarian endometrioma, which was inversely related to the prevalence rate of endometriosis (from the highest of 30.80% in recalled endometriosis to the lowest of 1.54% in tissue-proved ovarian endometrioma). The risk of EOC in women with endometriosis varied greatly by different criteria used. Women with endometriosis might have a more apparently higher risk than those reported by systematic review and meta-analysis.


Subject(s)
Endometriosis/complications , Endometriosis/diagnosis , Neoplasms, Glandular and Epithelial/epidemiology , Ovarian Neoplasms/epidemiology , Adult , Carcinoma, Ovarian Epithelial , Case-Control Studies , Catastrophic Illness , Cohort Studies , Databases, Factual , Endometriosis/epidemiology , Female , Humans , Incidence , Middle Aged , National Health Programs , Neoplasms, Glandular and Epithelial/diagnosis , Ovarian Neoplasms/diagnosis , Registries , Risk Factors , Taiwan/epidemiology , Young Adult
10.
Taiwan J Obstet Gynecol ; 53(4): 530-5, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25510696

ABSTRACT

OBJECTIVE: There is a possible correlation between endometriosis and an increased risk of epithelial ovarian cancer (EOC), but many uncertainties remain, including race, exposure or surveillance time, and surgical confirmation. Therefore, we carried out a large-scale, nationwide, controlled cohort study in the Taiwanese women to respond to these uncertainties. MATERIALS AND METHODS: A historical cohort study was performed by linking the National Health Insurance Research Database of Taiwan. Each patient diagnosed with endometriosis (n = 7537) between 2000 and 2009 was background matched with up to two women without endometriosis (n = 15,074). The total was 136,643 person-years of follow-up and 24 women having new EOC. Cox regression analysis was used to determine the relationship between the EOC incidence rate and an endometriosis status. RESULTS: The EOC incidence rate of the endometriosis and non-endometriosis women was 3.31 per 10,000 person-years and 0.99 per 10,000 person-years, respectively, contributing to an adjusted hazard ratio (HR) of 3.28 (95% confidence interval, 1.37-7.85). The women with surgical confirmation had a much higher adjusted HR (3.87; 95% confidence interval, 1.58-9.47). No significantly statistical difference of surveillance time between women with and without endometriosis (3.87 years vs. 3.73 years). The occurrence of EOC was not also affected by exposure time of women with endometriosis. CONCLUSION: Taiwanese women with endometriosis really had a risk of newly developed EOC, especially those who had a surgical diagnosis, and this three-fold increase of risk was neither influenced by exposure time nor biased by surveillance.


Subject(s)
Endometriosis/complications , Neoplasms, Glandular and Epithelial/etiology , Ovarian Neoplasms/etiology , Adult , Carcinoma, Ovarian Epithelial , Case-Control Studies , Cohort Studies , Databases, Factual , Female , Humans , Incidence , Middle Aged , Neoplasms, Glandular and Epithelial/epidemiology , Ovarian Neoplasms/epidemiology , Proportional Hazards Models , Retrospective Studies , Risk Factors , Taiwan
11.
BMC Cancer ; 14: 831, 2014 Nov 18.
Article in English | MEDLINE | ID: mdl-25403543

ABSTRACT

BACKGROUND: Epidemiological evidence of relationships between endometriosis and epithelial ovarian cancer (EOC) has been obtained mainly from Western countries. Our goal was to determine the risk of EOC due to endometriosis in Taiwanese women. METHODS: A retrospective cohort study was performed by linking to the National Health Insurance Research Database (NHIRD) of Taiwan. A total of 5,945 women with a new surgico-pathological diagnosis of endometriosis from 2000 to 2010 and 23,780 multivariable-matched controls (1:4) were selected. The Cox regression model adjusted for potential confounders was used to assess the risk of EOC due to endometriosis. RESULTS: The EOC incidence rate (IR) of the women with and without endometriosis was 11.64 and 2.66 per 10,000 person-years, contributing to a crude hazard ratio (HR) of 4.48 (95% confidence interval [CI] 2.84-7.06), and HR after adjustment for all confounders (adjusted HR) of 5.62 (95% CI 3.46-9.14); the risk was higher in clear-cell carcinoma subtypes (adjusted HR 7.36, 95% CI 1.91-28.33). The EOC IR of women with endometriosis consistently increased with increasing age, ranging from 4.99 (<30 years) to 35.81 (≥50 years) per 10,000 person-years, contributing to a progressively increased risk of EOC (crude HRs ranging from 2.80 to 6.74 and adjusted HRs ranging from 3.34 to 9.63) compared to age-matched women without endometriosis, whose EOC IR also increased with age. The older women (≥50 years) with endometriosis had a risk of EOC that was higher than both the age-matched women without endometriosis (adjusted HR 9.63, 95% CI 3.27-28.37) and the youngest women (<30 years) with endometriosis (adjusted HR 4.97, 95% CI 1.03-24.09). CONCLUSIONS: These significant findings corroborate the previously reported association between endometriosis and increased risk of EOC. Since the risk of EOC in women with a new surgico-pathological diagnosis of endometriosis constantly increased with age and this increased risk of EOC was more significant in women aged ≥50 years, active and intensive surgical intervention should be taken into consideration for older women with endometriosis.


Subject(s)
Adenocarcinoma, Clear Cell/etiology , Endometriosis/complications , Neoplasms, Glandular and Epithelial/etiology , Ovarian Neoplasms/etiology , Adenocarcinoma, Clear Cell/epidemiology , Adult , Age Factors , Carcinoma, Ovarian Epithelial , Case-Control Studies , Endometriosis/pathology , Endometriosis/surgery , Female , Follow-Up Studies , Humans , Incidence , Middle Aged , Neoplasms, Glandular and Epithelial/epidemiology , Ovarian Neoplasms/epidemiology , Proportional Hazards Models , Retrospective Studies , Risk Factors , Taiwan/epidemiology , Time Factors
12.
Article in English | MEDLINE | ID: mdl-24191169

ABSTRACT

The rhizome of Davallia formosana is commonly used to treat bone disease including bone fracture, arthritis, and osteoporosis in Chinese herbal medicine. Here, we report the effects of WL1101, the ethanol extracts of fresh rhizomes of Davallia formosana on ovariectomy-induced osteoporosis. In addition, excess activated bone-resorbing osteoclasts play crucial roles in inflammation-induced bone loss diseases, including rheumatoid arthritis and osteoporosis. In this study, we examined the effects of WL1101 on receptor activator of nuclear factor- κ B ligand (RANKL)-induced osteoclastogenesis. Treatment with WL1101 significantly inhibited RANKL-stimulated osteoclastogenesis. Two isolated active compounds, ((-)-epicatechin) or WL14 (4-hydroxy-3-aminobenzoic acid) could also inhibit RANKL-induced osteoclastogenesis. WL1101 suppressed the RANKL-induced nuclear factor- κ B (NF- κ B) activation and nuclear translocation, which is the key process during osteoclastogenesis, by inhibiting the activation of I κ B kinase (IKK) and I κ B α . In animal model, oral administration of WL1101 (50 or 200 mg/kg/day) effectively decreased the excess bone resorption and significantly antagonized the trabecular bone loss in ovariectomized rats. Our results demonstrate that the ethanol extracts of fresh rhizomes of Davallia formosana inhibit osteoclast differentiation via the inhibition of NF- κ B activation and effectively ameliorate ovariectomy-induced osteoporosis. WL1101 may thus have therapeutic potential for the treatment of diseases associated with excessive osteoclastic activity.

13.
J Chin Med Assoc ; 76(8): 452-7, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23746534

ABSTRACT

BACKGROUND: The management of ovarian tumors during pregnancy can be challenging because of the risk of fetal wastage and the possibility of surgery-related complications, or a delayed diagnosis of a possibly lethal disease or malignancy. The aim of this study was to study the characteristics and outcomes of pregnant women undergoing surgical intervention for ovarian tumors during pregnancy. METHODS: We reviewed the data of 102 pregnant women who underwent ovarian surgery between 2000 and 2010 at Taipei Veterans General Hospital, Taiwan. Data subject to analysis included gestational age at the time of surgery, complications, surgical and pathological findings, and the outcome of pregnancy. RESULTS: Fifty-two women who underwent surgery were excluded, whether by cesarean section, during the postpartum period or during simultaneous abortion surgery. Ultimately, the data of 50 patients were analyzed. Almost all patients (n = 46, 92%) were asymptomatic and underwent elective surgery. Frequently, this surgery was done in the second trimester (n = 35, 70%). We determined that teratoma (26%), mucinous cystadenomas (20%), and endometriomas (16%) were the three most common pathological findings. Nonspecific ovarian tumors were common (28%), including seven corpus luteum cysts, six simple cysts, and one paratubal cyst. Two women were diagnosed with malignant ovarian tumors, but both were metastatic and the primary site was the colon. Ten women underwent laparoscopic surgery. General anesthesia was used in four patients, and all underwent emergency exploratory laparotomy. There was no surgery-related complication or instance of preterm labor. CONCLUSION: In our study cohort, surgical intervention during pregnancy was safe, since neither surgical approach, such as exploratory laparotomy or laparoscopic surgery, nor anesthesia methods, for example general anesthesia or spinal anesthesia showed negative impact on the pregnancy outcomes. Reported cases of malignant ovarian tumor are still rare, thus, the possibility of metastatic tumor should be considered first.


Subject(s)
Ovarian Neoplasms/surgery , Ovary/surgery , Pregnancy Complications, Neoplastic/surgery , Adult , Female , Humans , Ovarian Neoplasms/pathology , Pregnancy , Pregnancy Complications, Neoplastic/pathology , Retrospective Studies
14.
Taiwan J Obstet Gynecol ; 52(1): 25-32, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23548214

ABSTRACT

OBJECTIVE: Cervicovaginitis is a highly prevalent disease that is a burden on healthcare globally. Immediate and adequate treatment can eradicate the infection and block subsequent complications. The feasibility of achip-based multiplexed immunoassay using liposomal nanovesicles was tested. MATERIALS AND METHODS: A multiplexed immunoassay chip containing five antibodies for five pathogens (Chlamydia trachomatis, Escherichia coli, Neisseria gonorrhoeae, Streptococcus agalactiae, and Candida albicans) was established and tested. Four patients with spiking of candidiasis were enrolled. The difference between positive and negative readings was evaluated using the paired Student t test. RESULTS: The detection threshold of Candida in this microarray was 100,000 CFU/mL in a vaginal sample, and the time required for the whole procedure was 3 hours. The testing of the four patients showed 100% for both sensitivity and specificity. CONCLUSION: This microarray chip was a rapid, easy, inexpensive and sensitive tool for detecting female lower genital tract Candida infection in a one-time vaginal sampling process, although the data on the four other pathogens were still unavailable. A larger population study is encouraged to test the validity of this multiplexed immunoassay chip.


Subject(s)
Immunoassay/methods , Microarray Analysis/methods , Nanostructures , Uterine Cervicitis/diagnosis , Vaginitis/diagnosis , Antibodies, Bacterial , Antibodies, Fungal , Candida albicans/immunology , Candidiasis, Vulvovaginal/diagnosis , Feasibility Studies , Female , Gram-Negative Bacteria/immunology , Gram-Negative Bacterial Infections/diagnosis , Humans , Immunoassay/instrumentation , Liposomes , Microarray Analysis/instrumentation , Sensitivity and Specificity , Streptococcal Infections/diagnosis , Streptococcus agalactiae/immunology , Uterine Cervicitis/microbiology , Vaginitis/microbiology
15.
Taiwan J Obstet Gynecol ; 52(1): 39-45, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23548216

ABSTRACT

OBJECTIVE: To assess the factors associated with future pregnancy and successful delivery in women who were treated for uterine adenomyoma with combination (surgical-medical) therapy using ultramini- or mini-laparotomy conservative surgery and gonadotropin-releasing hormone agonist. MATERIALS AND METHODS: One hundred and two women were evaluated. Items for analysis included: age, body mass index, and conception history; clinical symptoms of dysmenorrhea and menorrhagia; tumor location and preoperative serum level of cancer antigen 125 (CA125); the intraoperative findings of the weight of the removed tumor, and the uterine cavity opening. RESULTS: After excluding those patients using contraception or searching for an assisted reproductive technique, a total of 56 women were enrolled for analysis. Twenty-three (41.1%) women had 27 clinical pregnancies after 3 years of follow-up; 15 went on to deliver a healthy live-born child; two delivered preterm but healthy babies; seven had elective abortions; four had spontaneous abortions; and one had an ectopic pregnancy. The women who had a successful delivery during the 3-year follow-up after treatment tended to be younger, with a lower body mass index, lower baseline analgesic usage score, and lower preoperative serum level of CA125, be nulliparous, and with an adenoma in an anterior location. The linear regression model showed that age and baseline analgesic usage score were independent predictors of successful delivery and accounted for 56.5% of the total variance related to successful delivery. CONCLUSION: Age was an important factor associated with future successful delivery, therefore, caution should be taken in considering the maintenance of future fertility in older women treated with surgical-medical therapy.


Subject(s)
Adenomyoma/therapy , Antineoplastic Agents, Hormonal/therapeutic use , Infertility, Female/prevention & control , Leuprolide/therapeutic use , Postoperative Complications/prevention & control , Uterine Neoplasms/therapy , Uterus/surgery , Adenomyoma/complications , Adult , Combined Modality Therapy , Dysmenorrhea/etiology , Female , Follow-Up Studies , Humans , Infertility, Female/etiology , Laparotomy , Linear Models , Menorrhagia/etiology , Middle Aged , Pregnancy , Severity of Illness Index , Treatment Outcome , Uterine Neoplasms/complications
16.
J Chin Med Assoc ; 76(6): 335-9, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23612056

ABSTRACT

BACKGROUND: Advanced maternal age (AMA) is the most frequent indication for amniocentesis in predicting balanced reciprocal translocations, and abnormal ultrasound findings are indications in predicting unbalanced reciprocal translocations; however, to date, no studies have focused on Robertsonian translocations. METHODS: A retrospective review was conducted on 16,749 pregnant women who underwent midtrimester amniocentesis between January 1981 and December 2010. Robertsonian translocations were identified in 39 cases. RESULTS: The percentage of Robertsonian translocations in all amniocentesis cases was 0.23% (39/16,749); 31 were balanced and eight were unbalanced. De novo abnormality occurred in 17 cases, or in 43.6% of all Robertsonian translocations. The two major indications for amniocentesis with a diagnosis of Robertsonian translocations were AMA (41.0%, n = 16) and a parent with abnormal karyotypes (18.0%, n = 7). The highest percentage of Robertsonian translocations was found in parents with abnormal karyotypes (2.8%, 7/252), but neither of the indications were clearly superior for detecting de novo Robertsonian translocations. CONCLUSION: Although AMA is an indication for amniocentesis in approximately two-fifths of cases with Robertsonian translocations, the indication of parent with abnormal karyotypes was more likely to lead to the detection of non-de novo Robertsonian translocations, suggesting that parents with abnormal karyotypes need careful prenatal consultation.


Subject(s)
Translocation, Genetic , Amniocentesis , Female , Humans , Karyotype , Pregnancy , Retrospective Studies , Taiwan
20.
Taiwan J Obstet Gynecol ; 51(4): 539-44, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23276556

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate the short-term therapeutic outcome of women with symptomatic uterine myomas treated with laparoscopic uterine vessel occlusion (LUVO) or laparoscopic myomectomy (LM). METHODS: Ninety-five patients with symptomatic, uncomplicated myomas warranting surgical treatment who expressed a strong desire to retain their uterus were included in this study. Fifty-two patients underwent LUVO and 43 underwent LM. The outcome was measured by comparing blood loss, surgical time, postoperative recovery, postoperative pain (visual analog scale), complications, and success rate in both groups. RESULTS: The general characteristics of the patients were similar in both groups. There were no statistical differences in febrile morbidity, complications, success rate, therapeutic efficacy (symptom relief), and satisfaction rate between the two groups. LUVO had advantages over LM, including less surgical time, minimal blood loss, lower visual analog scale score, and rapid postoperative recovery. CONCLUSIONS: Both LUVO and LM might be effective in the management of symptomatic myomas in selected cases, but LUVO seemed to be more acceptable and less invasive in this 1-year short-term follow-up.


Subject(s)
Leiomyoma/surgery , Uterine Artery Embolization , Uterine Myomectomy , Uterine Neoplasms/surgery , Adult , Blood Loss, Surgical , Chi-Square Distribution , Female , Humans , Laparoscopy , Middle Aged , Operative Time , Pain, Postoperative/etiology , Recurrence , Treatment Outcome , Uterine Artery Embolization/adverse effects , Uterine Myomectomy/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL